Company
Minerva Neurosciences
Minerva Neurosciences has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Roluperidone | Phase 3 | Negative Symptoms of Schizophrenia |
Latest
No recent events.
Follow Minerva Neurosciences on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.